1. Home
  2. AGM vs MLYS Comparison

AGM vs MLYS Comparison

Compare AGM & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Agricultural Mortgage Corporation

AGM

Federal Agricultural Mortgage Corporation

HOLD

Current Price

$223.70

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$25.62

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGM
MLYS
Founded
1987
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
AGM
MLYS
Price
$223.70
$25.62
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$215.00
$48.67
AVG Volume (30 Days)
81.4K
722.4K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
3.71%
N/A
EPS Growth
1.09
37.43
EPS
10.15
N/A
Revenue
N/A
N/A
Revenue This Year
$25.97
N/A
Revenue Next Year
$12.21
N/A
P/E Ratio
$21.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$136.57
$22.00
52 Week High
$248.29
$47.65

Technical Indicators

Market Signals
Indicator
AGM
MLYS
Relative Strength Index (RSI) 54.50 42.23
Support Level $166.64 $22.36
Resistance Level $240.49 $30.90
Average True Range (ATR) 5.52 1.09
MACD -2.21 -0.06
Stochastic Oscillator 33.78 15.96

Price Performance

Historical Comparison
AGM
MLYS

About AGM Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven reportable segments: Farm & Ranch, which generates maximum revenue, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA. Geographically, the company's operations are spread across different regions in the United States.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Share on Social Networks: